ATXA Therapeutics wins NovaUCD’s 2024 Innovation AwardLeigh Mc Gowranon April 12, 2024 at 12:16 Silicon RepublicSilicon Republic

0

ATXA is a UCD spin-out that is developing small molecule drugs to treat pulmonary arterial hypertension.

Read more: ATXA Therapeutics wins NovaUCD’s 2024 Innovation Award

Leave a Comment